Cyclopentane Neuraminidase Inhibitors With Potent In Vitro Anti-Influenza Virus Activities
Document Type
Article
Journal/Book Title/Conference
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
Volume
45
Publication Date
2001
First Page
743
Last Page
748
Abstract
A novel series of cyclopentane derivatives have been found to exhibit potent and selective inhibitory effects on influenza virus neuraminidase. These compounds, designated RWJ-270201, BCX-1827, BCX-1898, and BCX-1923, were tested in parallel with zanamivir and oseltamivir carboxylate against a spectrum of influenza A (H1N1, H3N2, and H5N1) and influenza B viruses in MDCK cells. Inhibition of viral cytopathic effect ascertained visually and by neutral red dye uptake was used, with 50% effective (virus-inhibitory) concentrations (EC50) determined. Against the H1N1 viruses A/Bayern/07/95, A/Beijing/262/95, A/PR/8/34, and A/Texas/36/91, EC50s (determined by neutral red assay) of the novel compounds were ≤1.5 μM. Twelve strains of H3N2 and two strains of avian H5N1 viruses were inhibited at
Recommended Citation
Smee, D.F., Huffman, J.H., Morrison, A.C., Barnard, D.L., Sidwell, R.W. 2001. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother. 45:743-748. PMID: 11181354
Comments
Antimicrob Agents Chemother. 45:743-748. PMID: 11181354